Huifeng Tang (Huifen Tang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Epstein Barr Virus

Signaling Pathway

Top Venues

Discover oncology

Cancer management and research

Infection and drug resistance

Hematology (Amsterdam, Netherlands)

This page only lists publications with an associated author ORCID identifier.

Publications

Huifeng Tang, Hui Zhou, Liang Zhang, Tingting Tang, Ning Li
Molecular mechanism of MLCK1 inducing 5-Fu resistance in colorectal cancer cells through activation of TNFR2/NF-κB pathway. Discover oncology 15 (1) (2024)
Huifeng Tang, Hui Zhou, Liang Zhang, Tingting Tang, Ning Li
Molecular mechanism of MLCK1 inducing 5-Fu resistance in colorectal cancer cells through activation of TNFR2/NF-κB pathway. Discover oncology 15 (1) (2024)
Huifeng Tang, Hui Zhou, Liang Zhang, Tingting Tang, Ning Li
Molecular mechanism of MLCK1 inducing 5-Fu resistance in colorectal cancer cells through activation of TNFR2/NF-κB pathway. Discover oncology 15 (1) (2024)
Liang-Shun You, Cunying Yao, Fan Yang, Qing Yang, Jianping Lan, Xiaolu Song, Jianping Shen, Xianfu Sheng, Xiaohui Chen, Huifeng Tang, Huifang Jiang, Haiying Wu, Shenxian Qian, Haitao Meng
Echinocandins versus Amphotericin B Against Candida tropicalis Fungemia in Adult Hematological Patients with Neutropenia: A Multicenter Retrospective Cohort Study. Infection and drug resistance 13 (2020)
Hui Zhou, Huifeng Tang, Ning Li, Hang Chen, Xiaohui Chen, Lei Gu, Liang Zhang, Guoyan Tian, Diehong Tao
MicroRNA-361-3p Inhibit the Progression of Lymphoma by the Wnt/β-Catenin Signaling Pathway. Cancer management and research 12 (2020)
Huifeng Tang, Hui Zhou, Juying Wei, Hui Liu, Wenbin Qian, Xiaohui Chen
Clinicopathologic significance and therapeutic implication of de novo CD5+ diffuse large B-cell lymphoma. Hematology (Amsterdam, Netherlands) 24 (1) (2019)